Publication

This paper details the emerging threat of biological products developed for therapeutic use falling into the hands of criminals or terrorists. The authors detail the potential misuses of pathogens by terrorist organizations and highlight the implications for the pharmaceutical industry. The paper states that the danger of misused biological products calls for the tightening of regulatory practices in the interest of public safety and security.